BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24384766)

  • 1. Antineoplastic DNA-binding compounds: intercalating and minor groove binding drugs.
    Mišković K; Bujak M; Baus Lončar M; Glavaš-Obrovac L
    Arh Hig Rada Toksikol; 2013 Dec; 64(4):593-602. PubMed ID: 24384766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoxazolidinyl polycyclic aromatic hydrocarbons as DNA-intercalating antitumor agents.
    Rescifina A; Chiacchio U; Corsaro A; Piperno A; Romeo R
    Eur J Med Chem; 2011 Jan; 46(1):129-36. PubMed ID: 21093966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents.
    Gao C; Li B; Zhang B; Sun Q; Li L; Li X; Chen C; Tan C; Liu H; Jiang Y
    Bioorg Med Chem; 2015 Apr; 23(8):1800-7. PubMed ID: 25778766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The search of DNA-intercalators as antitumoral drugs: what it worked and what did not work.
    Martínez R; Chacón-García L
    Curr Med Chem; 2005; 12(2):127-51. PubMed ID: 15638732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncovalent Binding to DNA: Still a Target in Developing Anticancer Agents.
    Portugal J; Barceló F
    Curr Med Chem; 2016; 23(36):4108-4134. PubMed ID: 27593961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisintercalating threading diacridines: relationships between DNA binding, cytotoxicity, and cell cycle arrest.
    Wakelin LP; Bu X; Eleftheriou A; Parmar A; Hayek C; Stewart BW
    J Med Chem; 2003 Dec; 46(26):5790-802. PubMed ID: 14667232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors.
    David-Cordonnier MH; Hildebrand MP; Baldeyrou B; Lansiaux A; Keuser C; Benzschawel K; Lemster T; Pindur U
    Eur J Med Chem; 2007 Jun; 42(6):752-71. PubMed ID: 17433851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of threading intercalators to target DNA.
    Howell LA; Gulam R; Mueller A; O'Connell MA; Searcey M
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6956-9. PubMed ID: 20980148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-DNA sequence-dependent interactions analysed by electric linear dichroism.
    Bailly C; Hénichart JP; Colson P; Houssier C
    J Mol Recognit; 1992 Dec; 5(4):155-71. PubMed ID: 1339484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intercalators as anticancer drugs.
    Braña MF; Cacho M; Gradillas A; de Pascual-Teresa B; Ramos A
    Curr Pharm Des; 2001 Nov; 7(17):1745-80. PubMed ID: 11562309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.
    Zhang Z; Yang Y; Zhang D; Wang Y; Qian X; Liu F
    Bioorg Med Chem; 2006 Oct; 14(20):6962-70. PubMed ID: 16828559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a protein recognizing minor groove binders-damaged DNA.
    Colella G; Bonfanti M; D'Incalci M; Broggini M
    Nucleic Acids Res; 1996 Nov; 24(21):4227-33. PubMed ID: 8932377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzo[f]azino[2,1-a]phthalazinium cations: novel DNA intercalating chromophores with antiproliferative activity.
    Martínez V; Burgos C; Alvarez-Builla J; Fernández G; Domingo A; García-Nieto R; Gago F; Manzanares I; Cuevas C; Vaquero JJ
    J Med Chem; 2004 Feb; 47(5):1136-48. PubMed ID: 14971893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA intercalators in cancer therapy: organic and inorganic drugs and their spectroscopic tools of analysis.
    Wheate NJ; Brodie CR; Collins JG; Kemp S; Aldrich-Wright JR
    Mini Rev Med Chem; 2007 Jun; 7(6):627-48. PubMed ID: 17584161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking studies on DNA intercalators.
    Gilad Y; Senderowitz H
    J Chem Inf Model; 2014 Jan; 54(1):96-107. PubMed ID: 24303988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase II antagonism and anticancer activity of coordinated derivatives of [RuCl(2)(C(6)H(6))(dmso)].
    Vashisht Gopal YN; Konuru N; Kondapi AK
    Arch Biochem Biophys; 2002 May; 401(1):53-62. PubMed ID: 12054487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between antitumor drugs and a double-stranded oligonucleotide studied by electrospray ionization mass spectrometry.
    Gabelica V; De Pauw E; Rosu F
    J Mass Spectrom; 1999 Dec; 34(12):1328-37. PubMed ID: 10587629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine.
    Dassonneville L; Bonjean K; De Pauw-Gillet MC; Colson P; Houssier C; Quetin-Leclercq J; Angenot L; Bailly C
    Biochemistry; 1999 Jun; 38(24):7719-26. PubMed ID: 10387011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta-carboline analog Mana-Hox causes mitotic aberration by interacting with DNA.
    Tu LC; Chen CS; Hsiao IC; Chern JW; Lin CH; Shen YC; Yeh SF
    Chem Biol; 2005 Dec; 12(12):1317-24. PubMed ID: 16356849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bifunctional platinum(II) complex capable of intercalation and hydrogen-bonding interactions with DNA: binding studies and cytotoxicity.
    Ma DL; Che CM
    Chemistry; 2003 Dec; 9(24):6133-44. PubMed ID: 14679525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.